E
858
vs
H
Hang Seng (Hong Kong)
Over the past 12 months, Extrawell Pharmaceutical Holdings Ltd has significantly outperformed Hang Seng (Hong Kong), delivering a return of +67% compared to the Hang Seng (Hong Kong)'s +21% growth.
Stocks Performance
858 vs Hang Seng (Hong Kong)
Performance Gap
858 vs Hang Seng (Hong Kong)
Performance By Year
858 vs Hang Seng (Hong Kong)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Extrawell Pharmaceutical Holdings Ltd
Glance View
Extrawell Pharmaceutical Holdings Ltd. engages in the marketing and distribution of pharmaceutical products. The company employs 169 full-time employees The firm mainly operates through three segments. The Manufacturing segment is engaged in the development, manufacture and sales of pharmaceutical products. Its manufactured products include Transfer Factor Oral Solution, Wisk and ZhouBang, among others. The Trading segment is engaged in the marketing and distribution of imported pharmaceutical products. Its imported products include GM 1, Millibar and Skin Cap. The Gene Development segment is engaged in the commercial exploitation and development of genome-related technologies.
